These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8292058)

  • 1. Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity.
    Wahhab A; Smith JR; Ganter RC; Moore DM; Hondrelis J; Matsoukas J; Moore GJ
    Arzneimittelforschung; 1993 Nov; 43(11):1157-68. PubMed ID: 8292058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transposition of the imidazole ring substituents of angiotensin mimetics related to Losartan.
    Smith JR; Wahhab A; Moore D; Ganter RC; Moore GJ
    Drug Des Discov; 1994 Nov; 12(2):113-9. PubMed ID: 9116166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of non-peptide angiotensin receptor antagonists with tetrazole replaced imidazole ring.
    Wahhab A; Smith J; Moore GJ
    Arzneimittelforschung; 1993 Aug; 43(8):828-30. PubMed ID: 8216436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 8. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antagonists of angiotensin II receptor].
    Karasek D; Adamski M; Grzeszczak W
    Postepy Hig Med Dosw; 1996; 50(1):21-32. PubMed ID: 8778711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.
    Shetty SS; DelGrande D
    J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177.
    Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
    J Hypertens Suppl; 1991 Dec; 9(6):S224-5. PubMed ID: 1818953
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamic, pharmacokinetic and clinical profile of the first orally active angiotensin II receptor antagonist.
    Reid JL
    Cardiologia; 1995 Dec; 40(12 Suppl 1):187. PubMed ID: 8903052
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of angiotensin II receptor antagonists on diethylstilbestrol-induced vascular changes in the rat anterior pituitary gland: a quantitative evaluation.
    Pawllkowski M; Grochal M; Kulig A; Zieliński K; Stepień H; Kunert-Radek J; Mucha S
    Histol Histopathol; 1996 Oct; 11(4):909-13. PubMed ID: 8930634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro.
    Pawlikowski M; Kunert-Radek J
    Biochem Biophys Res Commun; 1997 Mar; 232(2):292-3. PubMed ID: 9125166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
    Zwart AS; Davis EA; Widdop RE
    Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptors in rabbit vascular grafts.
    Hausner EA; Turner MJ; Trzaskos JM; Herblin WF
    Biochem Biophys Res Commun; 1993 Jan; 190(1):27-32. PubMed ID: 8422252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans.
    Huskey SE; Miller RR; Chiu SH
    Drug Metab Dispos; 1993; 21(5):792-9. PubMed ID: 7902238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption and glucuronidation of the angiotensin II receptor antagonist losartan by the rat intestine.
    Krieter PA; Colletti AE; Miller RR; Stearns RA
    J Pharmacol Exp Ther; 1995 May; 273(2):816-22. PubMed ID: 7752085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.